CVRdatabase
Menu

ARXX Therapeutics ApS

Private limited companyCVR 40868151HerlevActive

ARXX Therapeutics ApS is a private limited company, based in Herlev, active in manufacture of pharmaceutical preparations, founded in 2019. Net profit rose 505% from 2024 to 2025, ending at DKK 707k. Equity grew to DKK 1.7m in 2025. 5 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 3.7m+43.5% vs. 2024
Net profitDKK 707k+505.3% vs. 2024
EquityDKK 1.7m+71.9% vs. 2024
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 20% (2024 → 2025), to DKK 2.8m.
  • Revenue rose 44% (2024 → 2025), to DKK 3.7m.
  • Net profit rose 505% (2024 → 2025), to DKK 707k.
  • Equity rose 72% (2024 → 2025), to DKK 1.7m.

Employees

  • 1 more employees than a year earlier: 3 (07/2026) against 2 (07/2025).

Management and owners, last 24 months

  • New in management: Jonas Hallén (director, 14/08/2025) and Berte Aagot Hedding Poulsson (director, 14/08/2025).
  • Stepped down: Farzad Abdi-Dezfuli (board member, 14/08/2025), Jonas Hallén (board member, 14/08/2025) and Susanne Stuffers (director, 14/08/2025) (+1).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 200kDKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4mDKK 1.6m202020212022202320242025
EquityNet profit
Financial figures for ARXX Therapeutics ApS
202020212022202320242025Change
Revenue2,1292,3975,7902,7912,6083,744+43.5%
Gross profit1,6651,6542,2231,8782,3332,788+19.5%
Operating profit (EBIT)033455236152912+499.5%
Profit before tax−377651275153907+493.8%
Net profit−377507270117707+505.3%
Total assets4197291,1731,2211,3511,927+42.6%
Equity971775968659821,689+71.9%
Liabilities322551577355369238−35.5%
Cash and cash equivalents2877211,068313348537+54.2%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5mDKK 3m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for ARXX Therapeutics ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202513/04/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202424/06/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202324/06/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202227/06/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202130/06/2022The companyPDF not statedXBRL
202001/10/2019 – 31/12/202006/07/2021The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
011223308/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 2.8mNo. 30 of 57
Better than 48% of the companies in the industry
EquityDKK 1.7mNo. 38 of 59
Better than 36% of the companies in the industry
Number of employees3No. 38 of 59
Better than 36% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bnHere
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 24,140of 69,742
Better than 65%
No. 26,578of 69,964
Better than 62%
Same industry and fewer than 20 employees37 companies in the comparison
No. 13of 36
Better than 66%
No. 19of 37
Better than 50%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 13,773of 33,588
Better than 59%
No. 11,899of 33,687
Better than 65%
All companies of type ApS66,508 companies in the comparison
No. 23,719of 66,379
Better than 64%
No. 22,610of 66,505
Better than 66%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. ARXX Therapeutics ApSDKK 2.8m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. ARXX Therapeutics ApSDKK 707k
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. ARXX Therapeutics ApSDKK 1.7m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. ARXX Therapeutics ApS3
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Arxx Therapeutics As100%
ARXX Therapeutics ApS

Management

2 active registrations

Executive management

Executive management at ARXX Therapeutics ApS
NameRoleAppointed
Jonas HallénDirector14/08/2025
Berte Aagot Hedding PoulssonDirector14/08/2025
Founders
Arxx Therapeutics As
Former management (4)
Former management at ARXX Therapeutics ApS
NameRoleAppointedResigned
Farzad Abdi-DezfuliBoard member01/10/201914/08/2025
Jonas HallénBoard member01/10/201914/08/2025
Susanne StuffersDirector01/10/201914/08/2025
Susanne StuffersChair of the board01/10/201914/08/2025

Signing rule: Selskabet tegnes af en direktør eller af den samlede direktion

Address and production units

1 active production units

Hørkær 12A
2730 Herlev

Herlev Municipality · Postcode 2730

Other companies at the address (5)

Production units
Production unitAddressEmployeesP number
ARXX Therapeutics ApSHørkær 12A, 2730 Herlev21025143708

Purpose

Selskabets formål er at udvikle, markedsføre og sælge lægemidler samt al virksomhed, som efter direktionens skøn er beslægtet hermed

The purpose is quoted from the register in Danish.

Changes year by year

20 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20257 changesmanagement 6 · accounts 1
  • Jonas Hallén appointed director
  • Berte Aagot Hedding Poulsson appointed director
  • Farzad Abdi-Dezfuli stepped down as board member
  • Jonas Hallén stepped down as board member
  • Susanne Stuffers stepped down as director
  • Susanne Stuffers stepped down as chair of the board
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20222 changesaccounts 1 · address 1
  • Annual report for 2021 published
  • Moved to Hørkær 12A, 2730 Herlev
20211 changeaccounts 1
  • Annual report for 2020 published
20201 changeaddress 1
  • Moved to Hørkær 12A, 2730 Herlev
20196 changesfounded 1 · management 4 · ownership 1
  • Registered as ARXX Therapeutics ApS
  • Farzad Abdi-Dezfuli appointed board member
  • Jonas Hallén appointed board member
  • Susanne Stuffers appointed director
  • Susanne Stuffers appointed chair of the board
  • ARXX THERAPEUTICS AS registered as owner (100%)

Related companies

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction